BIRC5 and osteosarcoma: We believed that the developed label-free electrochemical DNA biosensor can serve as a potential candidate for the sensitive and accurate determination of the survivin gene in complicated serum milieu, which is promising for the clinical diagnosis of osteosarcoma.